Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CHRSCHRS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in COHERUS ONCOLOGY INC

GOLDMAN SACHS GROUP INC holds 602,075 shares of CHRS (COHERUS ONCOLOGY INC), worth $842,905 as of 2026-Q2. The position was decreased (-13.5% shares). CHRS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$842,905

Current Shares

602,075

Total Value Change

+$105,005

Total Shares Change

+67,365

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
602,075
-13.5%
$842,9050.0%$1.40
0
2026-Q1
Increased
696,158
+126.7%
$1.2M0.0%$1.65
41
2025-Q4
Decreased
307,137
-19.8%
$436,1350.0%$1.41
0
2025-Q3
Increased
382,780
+15.6%
$627,7590.0%$1.70
28
2025-Q2
Decreased
331,117
-39.5%
$242,1460.0%$0.74
0
2025-Q1
Increased
547,707
+2.4%
$442,0000.0%$0.84
25
2024-Q4
New
534,710
-
$737,9000.0%$1.50
34

Other major holders of CHRS: BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used